Skip to main content
Clinical Trials/EUCTR2012-003987-34-BE
EUCTR2012-003987-34-BE
Active, not recruiting
Phase 1

Therapeutic interventions on senescence markers after human kidney transplantation, does metformine meets his expectations?”

Z Leuven0 sites50 target enrollmentJanuary 23, 2013

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Kidney transplant patients 3 months after TX, witha stable kidney function, no signs of graft failure.No other conditions like heart failure, diabetes, ....
Sponsor
Z Leuven
Enrollment
50
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 23, 2013
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Z Leuven

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria
  • Renal transplant patients
  • Baseline biopsy on day of transplantation
  • Inclusion on day of first protocol biopsy (month 3\) in case of stable renal function
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 45
  • F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • Exclusion criteria
  • Unstable or acute congestive heart failure (Ejection fraction \< 45%)
  • Lung disease
  • Liver disease
  • GFR \< 30 ml/min
  • Diabetes Mellitus
  • Past history of lactic acidosis
  • Alcohol abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials